123 related articles for article (PubMed ID: 19109540)
1. Costs of stroke using patient-level data: a critical review of the literature.
Luengo-Fernandez R; Gray AM; Rothwell PM
Stroke; 2009 Feb; 40(2):e18-23. PubMed ID: 19109540
[TBL] [Abstract][Full Text] [Related]
2. Estimating the long-term costs of ischemic and hemorrhagic stroke for Australia: new evidence derived from the North East Melbourne Stroke Incidence Study (NEMESIS).
Cadilhac DA; Carter R; Thrift AG; Dewey HM
Stroke; 2009 Mar; 40(3):915-21. PubMed ID: 19182091
[TBL] [Abstract][Full Text] [Related]
3. Cost avoidance associated with optimal stroke care in Canada.
Krueger H; Lindsay P; Cote R; Kapral MK; Kaczorowski J; Hill MD
Stroke; 2012 Aug; 43(8):2198-206. PubMed ID: 22627985
[TBL] [Abstract][Full Text] [Related]
4. Inpatient costs of specific cerebrovascular events at five academic medical centers.
Holloway RG; Witter DM; Lawton KB; Lipscomb J; Samsa G
Neurology; 1996 Mar; 46(3):854-60. PubMed ID: 8618712
[TBL] [Abstract][Full Text] [Related]
5. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
[TBL] [Abstract][Full Text] [Related]
6. International comparison of stroke cost studies.
Evers SM; Struijs JN; Ament AJ; van Genugten ML; Jager JH; van den Bos GA
Stroke; 2004 May; 35(5):1209-15. PubMed ID: 15073405
[TBL] [Abstract][Full Text] [Related]
7. Acute treatment costs of intracerebral hemorrhage and ischemic stroke in Argentina.
Christensen MC; Previgliano I; Capparelli FJ; Lerman D; Lee WC; Wainsztein NA
Acta Neurol Scand; 2009 Apr; 119(4):246-53. PubMed ID: 18771525
[TBL] [Abstract][Full Text] [Related]
8. How has the impact of 'care pathway technologies' on service integration in stroke care been measured and what is the strength of the evidence to support their effectiveness in this respect?
Allen D; Rixson L
Int J Evid Based Healthc; 2008 Mar; 6(1):78-110. PubMed ID: 21631815
[TBL] [Abstract][Full Text] [Related]
9. [The cost of schizophrenia: a literature review].
Charrier N; Chevreul K; Durand-Zaleski I
Encephale; 2013 May; 39 Suppl 1():S49-56. PubMed ID: 23351935
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of antiplatelet agents in secondary stroke prevention: the limits of certainty.
Matchar DB; Samsa GP; Liu S
Value Health; 2005; 8(5):572-80. PubMed ID: 16176495
[TBL] [Abstract][Full Text] [Related]
11. Development and application of Model of Resource Utilization, Costs, and Outcomes for Stroke (MORUCOS): an Australian economic model for stroke.
Mihalopoulos C; Cadilhac DA; Moodie ML; Dewey HM; Thrift AG; Donnan GA; Carter RC
Int J Technol Assess Health Care; 2005; 21(4):499-505. PubMed ID: 16262974
[TBL] [Abstract][Full Text] [Related]
12. Economic evaluation of drugs in peripheral vascular disease and stroke.
Drummond M; Davies L
J Cardiovasc Pharmacol; 1994; 23 Suppl 3():S4-7. PubMed ID: 7517476
[TBL] [Abstract][Full Text] [Related]
13. Medical resource use and costs of health care after acute stroke in Germany.
Rossnagel K; Nolte CH; Muller-Nordhorn J; Jungehulsing GJ; Selim D; Bruggenjurgen B; Villringer A; Willich SN
Eur J Neurol; 2005 Nov; 12(11):862-8. PubMed ID: 16241975
[TBL] [Abstract][Full Text] [Related]
14. Predicting the cost of illness: a comparison of alternative models applied to stroke.
Lipscomb J; Ancukiewicz M; Parmigiani G; Hasselblad V; Samsa G; Matchar DB
Med Decis Making; 1998; 18(2 Suppl):S39-56. PubMed ID: 9566466
[TBL] [Abstract][Full Text] [Related]
15. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
Whitfield MD; Gillett M; Holmes M; Ogden E
Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the costs and payments of a coordinated stroke center and regional stroke network.
Rymer MM; Armstrong EP; Meredith NR; Pham SV; Thorpe K; Kruzikas DT
Stroke; 2013 Aug; 44(8):2254-9. PubMed ID: 23715961
[TBL] [Abstract][Full Text] [Related]
17. Cognitive impairment after stroke - impact on activities of daily living and costs of care for elderly people. The Göteborg 70+ Stroke Study.
Claesson L; Lindén T; Skoog I; Blomstrand C
Cerebrovasc Dis; 2005; 19(2):102-9. PubMed ID: 15608434
[TBL] [Abstract][Full Text] [Related]
18. Economic burden of schizophrenia: empirical analyses from a survey in Thailand.
Phanthunane P; Whiteford H; Vos T; Bertram M
J Ment Health Policy Econ; 2012 Mar; 15(1):25-32. PubMed ID: 22611090
[TBL] [Abstract][Full Text] [Related]
19. Are cost benefits of anticoagulation for stroke prevention in atrial fibrillation underestimated?
Miller PS; Andersson FL; Kalra L
Stroke; 2005 Feb; 36(2):360-6. PubMed ID: 15637326
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of thrombolysis within 4.5 hours of acute ischemic stroke: experience from Australian stroke center.
Tan Tanny SP; Busija L; Liew D; Teo S; Davis SM; Yan B
Stroke; 2013 Aug; 44(8):2269-74. PubMed ID: 23780955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
